Department of Otorhinolaryngology-Head & Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Acta Otorhinolaryngol Ital. 2023 Apr;43(2):99-107. doi: 10.14639/0392-100X-N2192.
Compare long-term outcomes of thyroid-split and standard thyroid-retraction tracheostomy in a large cohort.
The healthcare database of a university-affiliated hospital was searched for past patients over 18 years of age from all of the hospital's wards on whom an ear, nose, and throat specialist performed a tracheostomy in the operating room between 2010 and 2020. Clinical data were extracted from the hospital and outpatient medical records. Life-threatening and non-life-threatening intra-operative and early and late post-operative adverse events in patients who underwent split-thyroid tracheostomy were compared with those who underwent standard tracheostomy.
There was no significant difference in intra-operative and early post-operative complications, hospitalisation length, or early reoperation and death rates between the 140 (28%) thyroid-split tracheostomy patients and the 354 (72%) standard tracheostomy patients, although the thyroid-split group had more non-decannulated patients and a longer operative time.
Thyroid-split tracheostomy is safe and feasible. Compared to the standard procedure, it provides better exposure and a similar rate of complications, although its de-cannulation success rate is lower.
在一个大样本中比较甲状腺劈开术和标准甲状腺牵拉术的长期结果。
检索一所大学附属医院的医疗保健数据库，检索年龄在 18 岁以上的过去患者，这些患者均由耳鼻喉科专家在 2010 年至 2020 年期间在手术室对所有病房的患者进行气管切开术。从医院和门诊病历中提取临床数据。比较接受甲状腺劈开术和标准气管切开术的患者的术中及术后早期的危及生命和非危及生命的不良事件以及术后早期和晚期的不良事件。
在 140 例（28%）甲状腺劈开组和 354 例（72%）标准气管切开组中，术中及术后早期并发症、住院时间、早期再手术率和死亡率均无显著差异，尽管甲状腺劈开组未拔管的患者更多，手术时间更长。
甲状腺劈开术是安全可行的。与标准手术相比，它提供了更好的暴露度和相似的并发症发生率，尽管其拔管成功率较低。
